Cargando…
A clinical indicator-based prognostic model predicting treatment outcomes of pulmonary tuberculosis: a prospective cohort study
OBJECTIVES: Identifying prognostic factors helps optimize the treatment regimen and promote favorable outcomes. We conducted a prospective cohort study on patients with pulmonary tuberculosis to construct a clinical indicator-based model and estimate its performance. METHODS: We performed a two-stag...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9940065/ https://www.ncbi.nlm.nih.gov/pubmed/36803117 http://dx.doi.org/10.1186/s12879-023-08053-x |
_version_ | 1784891000046485504 |
---|---|
author | Zhan, Mengyao Xue, Hao Wang, Yuting Wu, Zhuchao Wen, Qin Shi, Xinling Wang, Jianming |
author_facet | Zhan, Mengyao Xue, Hao Wang, Yuting Wu, Zhuchao Wen, Qin Shi, Xinling Wang, Jianming |
author_sort | Zhan, Mengyao |
collection | PubMed |
description | OBJECTIVES: Identifying prognostic factors helps optimize the treatment regimen and promote favorable outcomes. We conducted a prospective cohort study on patients with pulmonary tuberculosis to construct a clinical indicator-based model and estimate its performance. METHODS: We performed a two-stage study by recruiting 346 pulmonary tuberculosis patients diagnosed between 2016 and 2018 in Dafeng city as the training cohort and 132 patients diagnosed between 2018 and 2019 in Nanjing city as the external validation population. We generated a risk score based on blood and biochemistry examination indicators by the least absolute shrinkage and selection operator (LASSO) Cox regression. Univariate and multivariate Cox regression models were used to assess the risk score, and the strength of association was expressed as the hazard ratio (HR) and 95% confidence interval (CI). We plotted the receiver operating characteristic (ROC) curve and calculated the area under the curve (AUC). Internal validation was conducted by 10-fold cross-validation. RESULTS: Ten significant indicators (PLT, PCV, LYMPH, MONO%, NEUT, NEUT%, TBTL, ALT, UA, and Cys-C) were selected to generate the risk score. Clinical indicator-based score (HR: 10.018, 95% CI: 4.904–20.468, P < 0.001), symptom-based score (HR: 1.356, 95% CI: 1.079–1.704, P = 0.009), pulmonary cavity (HR: 0.242, 95% CI: 0.087–0.674, P = 0.007), treatment history (HR: 2.810, 95% CI: 1.137–6.948, P = 0.025), and tobacco smoking (HR: 2.499, 95% CI: 1.097–5.691, P = 0.029) were significantly related to the treatment outcomes. The AUC was 0.766 (95% CI: 0.649–0.863) in the training cohort and 0.796 (95% CI: 0.630–0.928) in the validation dataset. CONCLUSION: In addition to the traditional predictive factors, the clinical indicator-based risk score determined in this study has a good prediction effect on the prognosis of tuberculosis. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12879-023-08053-x. |
format | Online Article Text |
id | pubmed-9940065 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-99400652023-02-21 A clinical indicator-based prognostic model predicting treatment outcomes of pulmonary tuberculosis: a prospective cohort study Zhan, Mengyao Xue, Hao Wang, Yuting Wu, Zhuchao Wen, Qin Shi, Xinling Wang, Jianming BMC Infect Dis Research OBJECTIVES: Identifying prognostic factors helps optimize the treatment regimen and promote favorable outcomes. We conducted a prospective cohort study on patients with pulmonary tuberculosis to construct a clinical indicator-based model and estimate its performance. METHODS: We performed a two-stage study by recruiting 346 pulmonary tuberculosis patients diagnosed between 2016 and 2018 in Dafeng city as the training cohort and 132 patients diagnosed between 2018 and 2019 in Nanjing city as the external validation population. We generated a risk score based on blood and biochemistry examination indicators by the least absolute shrinkage and selection operator (LASSO) Cox regression. Univariate and multivariate Cox regression models were used to assess the risk score, and the strength of association was expressed as the hazard ratio (HR) and 95% confidence interval (CI). We plotted the receiver operating characteristic (ROC) curve and calculated the area under the curve (AUC). Internal validation was conducted by 10-fold cross-validation. RESULTS: Ten significant indicators (PLT, PCV, LYMPH, MONO%, NEUT, NEUT%, TBTL, ALT, UA, and Cys-C) were selected to generate the risk score. Clinical indicator-based score (HR: 10.018, 95% CI: 4.904–20.468, P < 0.001), symptom-based score (HR: 1.356, 95% CI: 1.079–1.704, P = 0.009), pulmonary cavity (HR: 0.242, 95% CI: 0.087–0.674, P = 0.007), treatment history (HR: 2.810, 95% CI: 1.137–6.948, P = 0.025), and tobacco smoking (HR: 2.499, 95% CI: 1.097–5.691, P = 0.029) were significantly related to the treatment outcomes. The AUC was 0.766 (95% CI: 0.649–0.863) in the training cohort and 0.796 (95% CI: 0.630–0.928) in the validation dataset. CONCLUSION: In addition to the traditional predictive factors, the clinical indicator-based risk score determined in this study has a good prediction effect on the prognosis of tuberculosis. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12879-023-08053-x. BioMed Central 2023-02-20 /pmc/articles/PMC9940065/ /pubmed/36803117 http://dx.doi.org/10.1186/s12879-023-08053-x Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Zhan, Mengyao Xue, Hao Wang, Yuting Wu, Zhuchao Wen, Qin Shi, Xinling Wang, Jianming A clinical indicator-based prognostic model predicting treatment outcomes of pulmonary tuberculosis: a prospective cohort study |
title | A clinical indicator-based prognostic model predicting treatment outcomes of pulmonary tuberculosis: a prospective cohort study |
title_full | A clinical indicator-based prognostic model predicting treatment outcomes of pulmonary tuberculosis: a prospective cohort study |
title_fullStr | A clinical indicator-based prognostic model predicting treatment outcomes of pulmonary tuberculosis: a prospective cohort study |
title_full_unstemmed | A clinical indicator-based prognostic model predicting treatment outcomes of pulmonary tuberculosis: a prospective cohort study |
title_short | A clinical indicator-based prognostic model predicting treatment outcomes of pulmonary tuberculosis: a prospective cohort study |
title_sort | clinical indicator-based prognostic model predicting treatment outcomes of pulmonary tuberculosis: a prospective cohort study |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9940065/ https://www.ncbi.nlm.nih.gov/pubmed/36803117 http://dx.doi.org/10.1186/s12879-023-08053-x |
work_keys_str_mv | AT zhanmengyao aclinicalindicatorbasedprognosticmodelpredictingtreatmentoutcomesofpulmonarytuberculosisaprospectivecohortstudy AT xuehao aclinicalindicatorbasedprognosticmodelpredictingtreatmentoutcomesofpulmonarytuberculosisaprospectivecohortstudy AT wangyuting aclinicalindicatorbasedprognosticmodelpredictingtreatmentoutcomesofpulmonarytuberculosisaprospectivecohortstudy AT wuzhuchao aclinicalindicatorbasedprognosticmodelpredictingtreatmentoutcomesofpulmonarytuberculosisaprospectivecohortstudy AT wenqin aclinicalindicatorbasedprognosticmodelpredictingtreatmentoutcomesofpulmonarytuberculosisaprospectivecohortstudy AT shixinling aclinicalindicatorbasedprognosticmodelpredictingtreatmentoutcomesofpulmonarytuberculosisaprospectivecohortstudy AT wangjianming aclinicalindicatorbasedprognosticmodelpredictingtreatmentoutcomesofpulmonarytuberculosisaprospectivecohortstudy AT zhanmengyao clinicalindicatorbasedprognosticmodelpredictingtreatmentoutcomesofpulmonarytuberculosisaprospectivecohortstudy AT xuehao clinicalindicatorbasedprognosticmodelpredictingtreatmentoutcomesofpulmonarytuberculosisaprospectivecohortstudy AT wangyuting clinicalindicatorbasedprognosticmodelpredictingtreatmentoutcomesofpulmonarytuberculosisaprospectivecohortstudy AT wuzhuchao clinicalindicatorbasedprognosticmodelpredictingtreatmentoutcomesofpulmonarytuberculosisaprospectivecohortstudy AT wenqin clinicalindicatorbasedprognosticmodelpredictingtreatmentoutcomesofpulmonarytuberculosisaprospectivecohortstudy AT shixinling clinicalindicatorbasedprognosticmodelpredictingtreatmentoutcomesofpulmonarytuberculosisaprospectivecohortstudy AT wangjianming clinicalindicatorbasedprognosticmodelpredictingtreatmentoutcomesofpulmonarytuberculosisaprospectivecohortstudy |